{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:26:07Z","timestamp":1790429167083,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007710","name":"University of Connecticut","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Immunology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.smim.2020.101387","type":"journal-article","created":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T16:48:57Z","timestamp":1579020537000},"page":"101387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Prediction of cancer neoepitopes needs new rules"],"prefix":"10.1016","volume":"47","author":[{"given":"Cory A.","family":"Brennick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam M.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod K.","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukrut H.","family":"Karandikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.smim.2020.101387_bib0005","first-page":"326","article-title":"Intradermal immunization of C3H mice against a sarcoma that originated in an animal of the same line","volume":"3","author":"Gross","year":"1943","journal-title":"Cancer Res."},{"key":"10.1016\/j.smim.2020.101387_bib0010","first-page":"769","article-title":"Immunity to methylcholanthrene-induced sarcomas","volume":"18","author":"Prehn","year":"1957","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.smim.2020.101387_bib0015","first-page":"1561","article-title":"Demonstration of resistance against methylcholanthreneinduced sarcomas in the primary autochthonous host","volume":"20","author":"Klein","year":"1960","journal-title":"Cancer Res."},{"key":"10.1016\/j.smim.2020.101387_bib0020","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006957","article-title":"T-cell tolerance: central and peripheral","volume":"4","author":"Xing","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.smim.2020.101387_bib0025","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1084\/jem.79.2.137","article-title":"Studies on the chemical nature of the substance inducing transformation of pneumococcal types: induction of transformation by a desoxyribonucleic acid fraction isolated from pneumococcus type Iii","volume":"79","author":"Avery","year":"1944","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.smim.2020.101387_bib0030","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1073\/pnas.72.12.5135","article-title":"Detection of carcinogens as mutagens in the Salmonella\/microsome test: assay of 300 chemicals","volume":"72","author":"McCann","year":"1975","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.smim.2020.101387_bib0035","doi-asserted-by":"crossref","first-page":"5714","DOI":"10.1073\/pnas.76.11.5714","article-title":"Passage of phenotypes of chemically transformed cells via transfection of DNA and chromatin","volume":"76","author":"Shih","year":"1979","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.smim.2020.101387_bib0040","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/290261a0","article-title":"Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts","volume":"290","author":"Shih","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.smim.2020.101387_bib0045","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1073\/pnas.79.9.2845","article-title":"Oncogenes in human tumor cell lines: molecular cloning of a transforming gene from human bladder carcinoma cells","volume":"79","author":"Pulciani","year":"1982","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.smim.2020.101387_bib0050","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/300149a0","article-title":"A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene","volume":"300","author":"Reddy","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.smim.2020.101387_bib0055","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/317359a0","article-title":"Binding of immunogenic peptides to Ia histocompatibility molecules","volume":"317","author":"Babbitt","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.smim.2020.101387_bib0060","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/351290a0","article-title":"Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules","volume":"351","author":"Falk","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.smim.2020.101387_bib0065","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1146\/annurev.iy.11.040193.001241","article-title":"Peptides naturally presented by MHC class I molecules","volume":"11","author":"Rammensee","year":"1993","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.smim.2020.101387_bib0070","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0065-230X(08)60318-8","article-title":"Peptide-binding heat shock proteins in the endoplasmic reticulum: role in immune response to cancer and in antigen presentation","volume":"62","author":"Srivastava","year":"1993","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.smim.2020.101387_bib0075","doi-asserted-by":"crossref","first-page":"7976","DOI":"10.1073\/pnas.92.17.7976","article-title":"A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma","volume":"92","author":"Coulie","year":"1995","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.smim.2020.101387_bib0080","first-page":"3718","article-title":"High frequency of cytolytic t lymphocytes directed against a tumor-specific mutated antigen detectable with HLA tetramers in the blood of a lung carcinoma patient with long survival","volume":"61","author":"Karanikas","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.smim.2020.101387_bib0085","first-page":"4078","article-title":"A point mutation in the \u03b1-Actinin-4 gene generates an antigenic peptide recognized by autologous cytolytic t lymphocytes on a human lung carcinoma","volume":"61","author":"Echchakir","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.smim.2020.101387_bib0090","doi-asserted-by":"crossref","first-page":"6057","DOI":"10.4049\/jimmunol.164.11.6057","article-title":"High frequency of autologous anti-melanoma CTL directed against an antigen generated by a point mutation in a new helicase gene","volume":"164","author":"Baurain","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2020.101387_bib0095","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/1074-7613(95)90078-0","article-title":"A unique tumor antigen produced by a single amino acid substitution","volume":"2","author":"Monach","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2020.101387_bib0100","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1158\/0008-5472.CAN-11-3722","article-title":"Exploiting the mutanome for tumor vaccination","volume":"72","author":"Castle","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.smim.2020.101387_bib0105","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature10755","article-title":"Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting","volume":"482","author":"Matsushita","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.smim.2020.101387_bib0110","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nature14001","article-title":"Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing","volume":"515","author":"Yadav","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.smim.2020.101387_bib0115","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature13988","article-title":"Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens","volume":"515","author":"Gubin","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.smim.2020.101387_bib0120","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1084\/jem.20141308","article-title":"Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity","volume":"211","author":"Duan","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.smim.2020.101387_bib0125","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1126\/science.aaa3828","article-title":"A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells","volume":"348","author":"Carreno","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.smim.2020.101387_bib0130","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature22991","article-title":"An immunogenic personal neoantigen vaccine for patients with melanoma","volume":"547","author":"Ott","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.smim.2020.101387_bib0135","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature23003","article-title":"Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer","volume":"547","author":"Sahin","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.smim.2020.101387_bib0140","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41586-018-0792-9","article-title":"Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial","volume":"565","author":"Keskin","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.smim.2020.101387_bib0145","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41586-018-0810-y","article-title":"Actively personalized vaccination trial for newly diagnosed glioblastoma","volume":"565","author":"Hilf","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.smim.2020.101387_bib0150","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev-immunol-032712-095910","article-title":"Pathways of antigen processing","volume":"31","author":"Blum","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.smim.2020.101387_bib0155","doi-asserted-by":"crossref","first-page":"5586","DOI":"10.4049\/jimmunol.153.12.5586","article-title":"The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes","volume":"153","author":"Sette","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2020.101387_bib0160","doi-asserted-by":"crossref","first-page":"7890","DOI":"10.4049\/jimmunol.178.12.7890","article-title":"A quantitative analysis of the variables affecting the repertoire of t cell specificities recognized after vaccinia virus infection","volume":"178","author":"Assarsson","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2020.101387_bib0165","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1110\/ps.0239403","article-title":"Reliable prediction of T-cell epitopes using neural networks with novel sequence representations","volume":"12","author":"Nielsen","year":"2003","journal-title":"Protein Sci. Publ. Protein Soc."},{"key":"10.1016\/j.smim.2020.101387_bib0170","series-title":"IEDB. IEDB Analysis Resource. Epitope Predict. Anal. Tools","year":"2019"},{"key":"10.1016\/j.smim.2020.101387_bib0175","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.127882","article-title":"Identification of epitopes in ovalbumin that provide insights for cancer neoepitopes","volume":"4","author":"Karandikar","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.smim.2020.101387_bib0180","article-title":"Identification of a neo-epitope dominating endogenous CD8 T cell responses to MC-38 colorectal cancer","volume":"0","author":"Hos","year":"2019","journal-title":"OncoImmunology"},{"key":"10.1016\/j.smim.2020.101387_bib0185","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1146\/annurev.iy.11.040193.003501","article-title":"Dominance and crypticity of t cell antigenic determinants","volume":"11","author":"Sercarz","year":"1993","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.smim.2020.101387_bib0190","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/eji.201141954","article-title":"Inefficient exogenous loading of a tapasin-dependent peptide onto HLA-B*44:02 can be improved by acid treatment or fixation of target cells","volume":"42","author":"Stroobant","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.smim.2020.101387_bib0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155189","article-title":"Low mutation burden in ovarian Cancer may limit the utility of neoantigen-targeted vaccines","volume":"11","author":"Martin","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.smim.2020.101387_bib0200","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/978-1-4939-7537-2_14","article-title":"Mass spectrometry based immunopeptidomics for the discovery of Cancer neoantigens","volume":"1719","author":"Bassani-Sternberg","year":"2018","journal-title":"Methods Mol. Biol. Clifton NJ"},{"key":"10.1016\/j.smim.2020.101387_bib0205","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.129152","article-title":"Mass spectrometry\u2013driven exploration reveals nuances of neoepitope-driven tumor rejection","volume":"4","author":"Ebrahimi-Nik","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.smim.2020.101387_bib0210","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1492508","article-title":"Predicting T cell recognition of MHC class I restricted neoepitopes","volume":"7","author":"Ko\u015falo\u011flu-Yal\u00e7\u0131n","year":"2018","journal-title":"OncoImmunology"},{"key":"10.1016\/j.smim.2020.101387_bib0215","first-page":"5","article-title":"T cell responses to viral infections \u2013 opportunities for peptide vaccination","author":"Rosendahl Huber","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2020.101387_bib0220","first-page":"9","article-title":"Features of effective t cell-inducing vaccines against chronic viral infections","author":"Panagioti","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2020.101387_bib0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117242","article-title":"Targeting of non-dominant antigens as a vaccine strategy to broaden T-Cell responses during chronic viral infection","volume":"10","author":"Holst","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.smim.2020.101387_bib0230","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1016\/j.vaccine.2006.12.038","article-title":"CTL epitopes for influenza A including the H5N1 bird flu; genome-, pathogen-, and HLA-wide screening","volume":"25","author":"Wang","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.smim.2020.101387_bib0235","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1172\/JCI200419418","article-title":"High vaccination efficiency of low-affinity epitopes in antitumor immunotherapy","volume":"113","author":"Gross","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.smim.2020.101387_bib0240","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/annonc\/mdx687","article-title":"Differential binding affinity of mutated peptides for MHC class I is a predictor of survival in advanced lung cancer and melanoma","volume":"29","author":"Ghorani","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.smim.2020.101387_bib0245","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1158\/2326-6066.CIR-17-0559","article-title":"Tumor immunity and survival as a function of alternative neopeptides in human Cancer","volume":"6","author":"Rech","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.smim.2020.101387_bib0250","first-page":"4","article-title":"CD91 on dendritic cells governs immunosurveillance of nascent, emerging tumors","author":"Sedlacek","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.smim.2020.101387_bib0255","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1016\/j.celrep.2019.07.106","article-title":"Sensitive detection and analysis of neoantigen-specific t cell populations from tumors and blood","volume":"28","author":"Peng","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.smim.2020.101387_bib0260","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1074-7613(00)80035-7","article-title":"TCR binding to Peptide-MHC stabilizes a flexible recognition interface","volume":"10","author":"Willcox","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2020.101387_bib0265","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/ni1257","article-title":"T cell receptor recognition of a \u2018super-bulged\u2019 major histocompatibility complex class I\u2013bound peptide","volume":"6","author":"Tynan","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2020.101387_bib0270","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1182\/blood-2012-06-437202","article-title":"Peptide length determines the outcome of TCR\/peptide-MHCI engagement","volume":"121","author":"Ekeruche-Makinde","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.smim.2020.101387_bib0275","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1074\/jbc.M113.522110","article-title":"T-cell receptor (TCR)-Peptide specificity overrides affinity-enhancing TCR-Major histocompatibility complex interactions","volume":"289","author":"Cole","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2020.101387_bib0280","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s12026-011-8204-3","article-title":"T cell recognition of weak ligands: roles of signaling, receptor number, and affinity","volume":"50","author":"Edwards","year":"2011","journal-title":"Immunol. Res."},{"key":"10.1016\/j.smim.2020.101387_bib0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000481","article-title":"Attenuated t cell responses to a high-potency ligand in vivo","volume":"8","author":"Corse","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.smim.2020.101387_bib0290","first-page":"2543","article-title":"Relating TCR-peptide-MHC affinity to immunogenicity for the design of tumor vaccines","volume":"116","author":"McMahan","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.smim.2020.101387_bib0295","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1406498","article-title":"Genetic basis for clinical response to CTLA-4 blockade in melanoma","volume":"371","author":"Snyder","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.smim.2020.101387_bib0300","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nature03954","article-title":"Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance","volume":"437","author":"Willimsky","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.smim.2020.101387_bib0305","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/s41591-018-0086-7","article-title":"Functional diversity and co-operativity between subclonal populations of paediatric glioblastoma and diffuse intrinsic pontine glioma cells","volume":"24","author":"Vinci","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.smim.2020.101387_bib0310","first-page":"7","article-title":"Rejection of immunogenic tumor clones is limited by clonal fraction","author":"Gejman","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.smim.2020.101387_bib0315","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/nbt.4282","article-title":"High-throughput determination of the antigen specificities of T cell receptors in single cells","volume":"36","author":"Zhang","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.smim.2020.101387_bib0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/1074-7613(95)90074-8","article-title":"T cell receptor antagonists and partial agonists","volume":"2","author":"Jameson","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2020.101387_bib0325","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1126\/science.7824949","article-title":"Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists","volume":"267","author":"Madrenas","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.smim.2020.101387_bib0330","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2020.101387_bib0335","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.smim.2020.101387_bib0340","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nature07657","article-title":"Complete but curtailed T-cell response to very low-affinity antigen","volume":"458","author":"Zehn","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.smim.2020.101387_bib0345","doi-asserted-by":"crossref","first-page":"15840","DOI":"10.1073\/pnas.262669499","article-title":"T cells take aim at cancer","volume":"99","author":"Pardoll","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.smim.2020.101387_bib0350","doi-asserted-by":"crossref","first-page":"6545","DOI":"10.4049\/jimmunol.1001867","article-title":"Reduced functional avidity promotes central and effector memory CD4 t cell responses to tumor-associated antigens","volume":"185","author":"Caserta","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2020.101387_bib0355","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.immuni.2016.07.021","article-title":"T cell factor 1-Expressing memory-like CD8+ t cells sustain the immune response to chronic viral infections","volume":"45","author":"Utzschneider","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2020.101387_bib0360","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","article-title":"Intratumoral Tcf1+PD-1+CD8+ t cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy","volume":"50","author":"Siddiqui","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2020.101387_bib0365","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.immuni.2018.11.014","article-title":"Checkpoint blockade immunotherapy induces dynamic changes in PD-1\u2212CD8+ tumor-infiltrating t cells","volume":"50","author":"Kurtulus","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2020.101387_bib0370","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nature22367","article-title":"Chromatin states define tumour-specific T cell dysfunction and reprogramming","volume":"545","author":"Philip","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.smim.2020.101387_bib0375","doi-asserted-by":"crossref","first-page":"9777","DOI":"10.1073\/pnas.0914127107","article-title":"Essential role of the Wnt pathway effector Tcf-1 for the establishment of functional CD8 T cell memory","volume":"107","author":"Jeannet","year":"2010","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.smim.2020.101387_bib0380","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.immuni.2010.08.002","article-title":"Differentiation and persistence of memory CD8+ t cells depend on t cell factor 1","volume":"33","author":"Zhou","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2020.101387_bib0385","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aai8593","article-title":"The TCF1-Bcl6 axis counteracts type I interferon to repress exhaustion and maintain T cell stemness","volume":"1","author":"Wu","year":"2016","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.smim.2020.101387_bib0390","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature19330","article-title":"Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy","volume":"537","author":"Im","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.smim.2020.101387_bib0395","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-1324-y","article-title":"TOX is a critical regulator of tumour-specific T cell differentiation","volume":"571","author":"Scott","year":"2019","journal-title":"Nature"}],"container-title":["Seminars in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532320300038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532320300038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T23:19:14Z","timestamp":1760915954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044532320300038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":79,"alternative-id":["S1044532320300038"],"URL":"https:\/\/doi.org\/10.1016\/j.smim.2020.101387","relation":{},"ISSN":["1044-5323"],"issn-type":[{"value":"1044-5323","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of cancer neoepitopes needs new rules","name":"articletitle","label":"Article Title"},{"value":"Seminars in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smim.2020.101387","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101387"}}